Hypothesis review: Are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder

Molecular Psychiatry

Volumn 17, Issue 7, 2012, Pages 669-681

  Schubert, K O ^a   Focking M ^a   Prehn, J H M ^b   Cotter, D R ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CAVEOLIN; CHLORPROMAZINE; CLATHRIN; DOPAMINE; DYSBINDIN; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID; PHOSPHATIDYLINOSITIDE; QUINPIROLE; TRIFLUOPERAZINE;

BIPOLAR DISORDER; CELL MIGRATION; DRUG EFFICACY; ENDOCYTOSIS; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; HYPOTHESIS; MEMBRANE TRANSPORT; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; PROTEOMICS; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; WHITE MATTER;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLATHRIN; ENDOCYTOSIS; GENETIC ASSOCIATION STUDIES; GENOMICS; HUMANS; MEMBRANE TRANSPORT MODULATORS; MODELS, BIOLOGICAL; NERVE FIBERS, MYELINATED; NEUROGENESIS; PROTEIN TRANSPORT; PROTEOMICS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; VESICULAR TRANSPORT PROTEINS;

EID: 84859617103     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.123     Document Type: Review

References (172)

1. van Os J, Kapur S. Schizophrenia. Lancet 2009; 374: 635-645.
2. Kleinman JE, Law AJ, Lipska BK, Hyde TM, Ellis JK, Harrison PJ et al. Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 2011; 69: 140-145.
3. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem 2009; 78: 857-902.
4. Schmid EM, McMahon HT. Integrating molecular and network biology to decode endocytosis. Nature 2007; 448: 883-888. (Pubitemid 47312770)
5. McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 2011; 12: 517-533.
6. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001; 2: 107-117. (Pubitemid 33674039)
7. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009; 10: 513-525.
8. Haucke V, Neher E, Sigrist SJ. Protein scaffolds in the coupling of synaptic exocytosis and endocytosis. Nat Rev Neurosci 2011; 12: 127-138.
9. Jovic M, Sharma M, Rahajeng J, Caplan S. The early endosome: a busy sorting station for proteins at the crossroads. Histol Histopathol 2010; 25: 99-112.
10. Luzio JP, Gray SR, Bright NA. Endosome-lysosome fusion. Biochem Soc Trans 2010; 38: 1413-1416.
11. FuW, Jiang Q, Zhang C. Novel functions of endocytic player clathrin in mitosis. Cell Res 2011; doi:10.1038/cr.2011/106 (in press).
12. Malhotra S, Kovats S, Zhang W, Coggeshall KM. B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. J Biol Chem 2009; 284: 24088-24097.
13. Shieh JC, Schaar BT, Srinivasan K, Brodsky FM, McConnell SK. Endocytosis regulates cell soma translocation and the distribution of adhesion proteins in migrating neurons. PLoS One 2011; 6: e17802.
14. Hoeller D, Volarevic S, Dikic I. Compartmentalization of growth factor receptor signalling. Curr Opin Cell Biol 2005; 17: 107-111. (Pubitemid 40380931)
15. Marsh M, Helenius A. Virus entry: open sesame. Cell 2006; 124: 729-740. (Pubitemid 43261448)
16. English JA, Dicker P, Focking M, Dunn MJ, Cotter DR. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 2009; 9: 3368-3382.
17. Föcking M, Dicker P, English JA, Schubert KO, Dunn MJ, Cotter DR. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry 2011; 68: 477-488.
18. Pennington K, Beasley CL, Dicker P, Fagan A, English J, Pariante CM et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry 2008; 13: 1102-1117.
19. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684-697, 643. (Pubitemid 38932173)
20. Schubert KO, Föcking M, Dicker P, Dunn MJ, Cotter DR. Proteomic analysis of the basic sub-proteome (pH 6-11) in the hippocampus in schizophrenia and bipolar affective disorder. Schizophr Res 2010; 117: 372.
21. Martins-De-Souza D, Dias-Neto E, Schmitt A, Falkai P, Gormanns P, Maccarrone G et al. Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry 2010; 11: 110-120.
22. Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC et al. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm 2009; 116: 275-289.
23. Ryder PV, Faundez V. Schizophrenia: the 'BLOC' may be in the endosomes. Sci Signal 2009; 2: pe66.
24. Kristiansen LV, Meador-Woodruff JH. Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression. Schizophr Res 2005; 78: 87-93. (Pubitemid 41188327)
25. McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 2007; 1127: 108-118. (Pubitemid 44854837)
26. Wieffer M, Maritzen T, Haucke V. SnapShot: endocytic trafficking. Cell 2009; 137: 382. e381-383.
27. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008; 40: 827-834. (Pubitemid 351913655)
28. Luan Z, Zhang Y, Lu T, Ruan Y, Zhang H, Yan J et al. Positive association of the human STON2 gene with schizophrenia. Neuroreport 2011; 22: 288-293.
29. Pimm J, McQuillin A, Thirumalai S, Lawrence J, Quested D, Bass N et al. The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia. Am J Hum Genet 2005; 76: 902-907. (Pubitemid 40563112)
30. Tang RQ, Zhao XZ, Shi YY, TangW, Gu NF, Feng GYet al. Familybased association study of Epsin 4 and schizophrenia. Mol Psychiatry 2006; 11: 395-399.
31. Escamilla M, Lee BD, Ontiveros A, Raventos H, Nicolini H, Mendoza R et al. The epsin 4 gene is associated with psychotic disorders in families of Latin American origin. Schizophr Res 2008; 106: 253-257.
32. Saint-Pol A, Yélamos B, Amessou M, Mills IG, Dugast M, Tenza D et al. Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev Cell 2004; 6: 525-538. (Pubitemid 38456181)
33. Wasiak S, Legendre-Guillemin V, Puertollano R, Blondeau F, Girard M, deHeuvel E et al. Enthoprotin: a novel clathrinassociated protein identified through subcellular proteomics. J Cell Biol 2002; 158: 855-862. (Pubitemid 35001077)
34. Wasiak S, Denisov AY, Han Z, Leventis PA, de Heuvel E, Boulianne GL et al. Characterization of a gamma-adaptin earbinding motif in enthoprotin. FEBS Lett 2003; 555: 437-442. (Pubitemid 37532589)
35. Chen H, De Camilli P. The association of epsin with ubiquitinated cargo along the endocytic pathway is negatively regulated by its interaction with clathrin. Proc Natl Acad Sci USA 2005; 102: 2766-2771. (Pubitemid 40299867)
36. Antonin W, Holroyd C, Fasshauer D, Pabst S, Von Mollard GF, Jahn R. A SNARE complex mediating fusion of late endosomes defines conserved properties of SNARE structure and function. EMBO J 2000; 19: 6453-6464.
37. Chidambaram S, Mü llers N,Wiederhold K, Haucke V, von Mollard GF. Specific interaction between SNAREs and epsin N-terminal homology (ENTH) domains of epsin-related proteins in trans-Golgi network to endosome transport. J BiolChem2004; 279: 4175-4179. (Pubitemid 38199003)
38. Honer WG, Falkai P, Bayer TA, Xie J, Hu L, Li HY et al. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex 2002; 12: 349-356. (Pubitemid 34226059)
39. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004; 113: 1353-1363. (Pubitemid 39069934)
40. Weickert CS, Rothmond DA, Hyde TM, Kleinman JE, Straub RE. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res 2008; 98: 105-110. (Pubitemid 350245587)
41. Ji Y, Yang F, Papaleo F, Wang HX, Gao WJ, Weinberger DR et al. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci USA 2009; 106: 19593-19598.
42. McPherson PS. Proteomic analysis of clathrin-coated vesicles. Proteomics 2010; 10: 4025-4039.
43. Miller SE, Collins BM, McCoy AJ, Robinson MS, Owen DJ. A SNARE-adaptor interaction is a new mode of cargo recognition in clathrin-coated vesicles. Nature 2007; 450: 570-574. (Pubitemid 350190254)
44. Di Pietro SM, Falcón-Pérez JM, Tenza D, Setty SR, Marks MS, Raposo G et al. BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. Mol Biol Cell 2006; 17: 4027-4038. (Pubitemid 44330885)
45. Salazar G, Craige B, Styers ML, Newell-Litwa KA, Doucette MM, Wainer BH et al. BLOC-1 complex deficiency alters the targeting of adaptor protein complex-3 cargoes. Mol Biol Cell 2006; 17: 4014-4026. (Pubitemid 44330884)
46. Jeans A, Malins R, Padamsey Z, Reinhart M, Emptage N. Increased expression of dysbindin-1A leads to a selective deficit in NMDA receptor signaling in the hippocampus. Neuropharmacology 2011; doi:10.1016/j.neuropharm. 2011.08.007 (in press).
47. Morris DW, Murphy K, Kenny N, Purcell SM, McGhee KA, Schwaiger S et al. Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biol Psychiatry 2008; 63: 24-31. (Pubitemid 350234879)
48. Boxall R, Porteous DJ, Thomson PA. DISC1 and Huntington's disease-overlapping pathways of vulnerability to neurological disorder? PLoS One 2011; 6: e16263.
49. Kvajo M, McKellar H, Gogos JA. Molecules, signaling, and schizophrenia. Curr Top Behav Neurosci 2010; 4: 629-656.
50. Sun T, Wu XS, Xu J, McNeil BD, Pang ZP, Yang W et al. The role of calcium/calmodulin-activated calcineurin in rapid and slow endocytosis at central synapses. J Neurosci 2010; 30: 11838-11847.
51. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 2009; 15: 509-518.
52. Ramström C, Chapman H, Viitanen T, Afrasiabi E, Fox H, Kivelä J et al. Regulation of HERG (KCNH2) potassium channel surface expression by diacylglycerol. Cell Mol Life Sci 2010; 67: 157-169.
53. Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007; 8: 413-426. (Pubitemid 46789232)
54. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EYet al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 2005; 8: 1051-1058. (Pubitemid 41061516)
55. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006; 12: 824-828. (Pubitemid 44050073)
56. Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 2005; 62: 263-272. (Pubitemid 40990971)
57. Fung SJ, Sivagnanasundaram S, Weickert CS. Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients. Biol Psychiatry 2011; 69: 71-79.
58. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68; image 45. (Pubitemid 40139588)
59. Maycox PR, Kelly F, Taylor A, Bates S, Reid J, Logendra R et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 2009; 14: 1083-1094.
60. Sorkina T, Hoover BR, Zahniser NR, Sorkin A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 2005; 6: 157-170.
61. Meisenzahl EM, Schmitt GJ, Scheuerecker J, Mö ller HJ. The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry 2007; 19: 337-345. (Pubitemid 47206979)
62. Schmitt GJ, la Fougère C, Dresel S, Frodl T, Hahn K, Mö ller HJ et al. Dual-isotope SPECT imaging of striatal dopamine: first episode, drug na?̈ve schizophrenic patients. Schizophr Res 2008; 101: 133-141.
63. Kim OJ, Gardner BR, Williams DB, Marinec PS, Cabrera DM, Peters JD et al. The role of phosphorylation in D1 dopamine receptor desensitization: evidence for a novel mechanism of arrestin association. J Biol Chem 2004; 279: 7999-8010. (Pubitemid 38294688)
64. Namkung Y, Dipace C, Urizar E, Javitch JA, Sibley DR. G proteincoupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation. J Biol Chem 2009; 284: 34103-34115.
65. Thompson D, Whistler JL. Trafficking properties of the d5 dopamine receptor. Traffic 2011; 12: 644-656.
66. Thompson D, Whistler JL. Dopamine D(3) receptors are downregulated following heterologous endocytosis by a specific interaction with G protein-coupled receptor-associated sorting protein-1. J Biol Chem 2011; 286: 1598-1608.
67. Paspalas CD, Rakic P, Goldman-Rakic PS. Internalization of D2 dopamine receptors is clathrin-dependent and select to dendroaxonic appositions in primate prefrontal cortex. Eur J Neurosci 2006; 24: 1395-1403. (Pubitemid 44401662)
68. Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 1996; 3: 241-253. (Pubitemid 26058365)
69. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008; 31: 234-242.
70. Scarr E, Beneyto M, Meador-Woodruff JH, Dean B. Cortical glutamatergic markers in schizophrenia. Neuropsychopharmacology 2005; 30: 1521-1531. (Pubitemid 41153124)
71. Harel A, Mattson MP, Yao PJ. CALM, a clathrin assembly protein, influences cell surface GluR2 abundance. Neuromolecular Med 2011; 13: 88-90.
72. Lewis DA. The chandelier neuron in schizophrenia. Dev Neurobiol 2011; 71: 118-127.
73. Kittler JT, Delmas P, Jovanovic JN, Brown DA, Smart TG, Moss SJ. Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J Neurosci 2000; 20: 7972-7977.
74. Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry 2009; 14: 601-613.
75. Castillo MA, Ghose S, Tamminga CA, Ulery-Reynolds PG. Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biol Psychiatry 2010; 67: 208-216.
76. Barakauskas VE, Beasley CL, Barr AM, Ypsilanti AR, Li HY, Thornton AE et al. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology 2010; 35: 1226-1238.
77. Harrison PJ, Eastwood SL. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 1998; 352: 1669-1673. (Pubitemid 28526126)
78. Pfeiffer SE,Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993; 3: 191-197. (Pubitemid 23156606)
79. Anitei M, Pfeiffer SE. Myelin biogenesis: sorting out protein trafficking. Curr Biol 2006; 16: R418-R421. (Pubitemid 43815758)
80. Winterstein C, Trotter J, Krämer-Albers EM. Distinct endocytic recycling of myelin proteins promotes oligodendroglial membrane remodeling. J Cell Sci 2008; 121(Pt 6): 834-842. (Pubitemid 351578119)
81. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003; 60: 443-456. (Pubitemid 36539053)
82. Lecuit T, Pilot F. Developmental control of cell morphogenesis: a focus on membrane growth. Nat Cell Biol 2003; 5: 103-108. (Pubitemid 36204192)
83. Park M, Salgado JM, Ostroff L, Helton TD, Robinson CG, Harris KM et al. Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes. Neuron 2006; 52: 817-830. (Pubitemid 44828451)
84. Shirane M, Nakayama KI. Protrudin induces neurite formation by directional membrane trafficking. Science 2006; 314: 818-821. (Pubitemid 44706648)
85. Alberts P, Galli T. The cell outgrowth secretory endosome (COSE): a specialized compartment involved in neuronal morphogenesis. Biol Cell 2003; 95: 419-424. (Pubitemid 37441632)
86. Arantes RM, Andrews NW. A role for synaptotagmin VIIregulated exocytosis of lysosomes in neurite outgrowth from primary sympathetic neurons. J Neurosci 2006; 26: 4630-4637. (Pubitemid 44315363)
87. Tojima T, Itofusa R, Kamiguchi H. Asymmetric clathrin-mediated endocytosis drives repulsive growth cone guidance. Neuron 2010; 66: 370-377.
88. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669. (Pubitemid 17099795)
89. Owen MJ, O'Donovan MC, Thapar A, Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry 2011; 198: 173-175.
90. Delay J, Deniker P. 38 cas de psychoses traits par la cure prolongee et continue de 4500 RP. Paper presented at: Renus du 1eme Congres des Alienistes et Neurologistes de Langue Francaise,1952; Luxembourg, July 21-27.
91. Rodemer C, Haucke V. Clathrin/AP-2-dependent endocytosis: a novel playground for the pharmacological toolbox? Handb Exp Pharmacol 2008; 186: 105-122.
92. Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993; 123: 1107-1117. (Pubitemid 23352421)
93. Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR et al. Antagonism of dopamine D2 receptor/betaarrestin 2. interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci USA 2008; 105: 13656-13661.
94. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, GainetdiRR, Caron MG. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005; 122: 261-273. (Pubitemid 41032989)
95. Vickery RG, von Zastrow M. Distinct dynamin-dependent and-independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes. J Cell Biol 1999; 144: 31-43. (Pubitemid 29047009)
96. Urban JD, Vargas GA, von Zastrow M, Mailman RB. Aripiprazole has functionally selective actions at dopamine D2 receptormediated signaling pathways. Neuropsychopharmacology 2007; 32: 67-77. (Pubitemid 44967785)
97. Schloesser RJ, Huang J, Klein PS, Manji HK. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008; 33: 110-133. (Pubitemid 350191320)
98. Chuang DM, Manji HK. In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked? Biol Psychiatry 2007; 62: 4-6. (Pubitemid 46898231)
99. Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V et al. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 2008; 132: 125-136.
100. Rossi M, Munarriz ER, Bartesaghi S, Milanese M, Dinsdale D, Guerra-Martin MA et al. Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J Cell Sci 2009; 122(Pt 18): 3330-3339.
101. Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67: 146-154.
102. Hedelin M, Lö f M, Olsson M, Lewander T, Nilsson B, Hultman CM et al. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychoticlike symptoms in a cohort of 33 000 women from the general population. BMC Psychiatry 2010; 10: 38.
103. Ben Gedalya T, Loeb V, Israeli E, Altschuler Y, Selkoe DJ, Sharon R. Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling. Traffic 2009; 10: 218-234.
104. Chernomordik LV, Leikina E, Frolov V, Bronk P, Zimmerberg J. An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids. J Cell Biol 1997; 136: 81-93. (Pubitemid 27044806)
105. English JA, Pennington K, Dunn MJ, Cotter DR. The neuroproteomics of schizophrenia. Biol Psychiatry 2011; 69: 163-172.
106. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
107. Owen MJ, Craddock N, O'Donovan MC. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch Gen Psychiatry 2010; 67: 667-673.
108. Rosenblatt A, Leroi I. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics 2000; 41: 24-30. (Pubitemid 30062894)
109. Pal A, Severin F, Lommer B, Shevchenko A, Zerial M. Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J Cell Biol 2006; 172: 605-618. (Pubitemid 43243880)
110. Wu F, Yao PJ. Clathrin-mediated endocytosis and Alzheimer's disease: an update. Ageing Res Rev 2009; 8: 147-149.
111. Kyriazis GA, Wei Z, Vandermey M, Jo DG, Xin O, Mattson MP et al. Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoformdependent manner: implications for Alzheimer disease pathogenesis. J Biol Chem 2008; 283: 25492-25502.
112. Schjeide BM, Schnack C, Lambert JC, Lill CM, Kirchheiner J, Tumani H et al. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Arch Gen Psychiatry 2011; 68: 207-213.
113. Jin J, Li GJ, Davis J, Zhu D, Wang Y, Pan C et al. Identification of novel proteins associated with both alpha-synuclein and DJ-1. Mol Cell Proteomics 2007; 6: 845-859. (Pubitemid 46831936)
114. Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 2011; 91: 119-149.
115. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, Kwon JM et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72: 722-727. (Pubitemid 36255971)
116. Tanabe K, Takei K. Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant. J Cell Biol 2009; 185: 939-948.
117. Erez H, Malkinson G, Prager-Khoutorsky M, De Zeeuw CI, Hoogenraad CC, Spira ME. Formation of microtubule-based traps controls the sorting and concentration of vesicles to restricted sites of regenerating neurons after axotomy. J Cell Biol 2007; 176: 497-507.
118. Giannandrea M, Bianchi V, Mignogna ML, Sirri A, Carrabino S, D'Elia E et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am J Hum Genet 2010; 86: 185-195.
119. Scarr E, Gray L, Keriakous D, Robinson PJ, Dean B. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disord 2006; 8: 133-143. (Pubitemid 44026765)
120. Bitoun M, Durieux AC, Prudhon B, Bevilacqua JA, Herledan A, Sakanyan V et al. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis. Hum Mutat 2009; 30: 1419-1427.
121. Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K et al. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 2002; 83: 797-806. (Pubitemid 35316029)
122. Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet 2010; 87: 229-236.
123. Cheng MC, Lu CL, Luu SU, Tsai HM, Hsu SH, Chen TT et al. Genetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia. PLoS One 2010; 5: e15107.
124. Hattori K, Fukuzako H, Hashiguchi T, Hamada S, Murata Y, Isosaka T et al. Decreased expression of Fyn protein and disbalanced alternative splicing patterns in platelets from patients with schizophrenia. Psychiatry Res 2009; 168: 119-128.
125. Braithwaite SP, Adkisson M, Leung J, Nava A, Masterson B, Urfer R et al. Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP). Eur J Neurosci 2006; 23: 2847-2856. (Pubitemid 43882863)
126. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-892. (Pubitemid 135750519)
127. Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005; 25: 4974-4984. (Pubitemid 40712840)
128. Mabb AM, Ehlers MD. Ubiquitination in postsynaptic function and plasticity. Annu Rev Cell Dev Biol 2010; 26: 179-210.
129. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood 3rd WH, Donovan DM et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001; 55: 641-650. (Pubitemid 32888383)
130. Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 571-578.
131. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22: 2718-2729. (Pubitemid 37465821)
132. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004; 61: 300-308. (Pubitemid 38295832)
133. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Yet al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005; 58: 85-96. (Pubitemid 41008124)
134. Chu TT, Liu Y, Kemether E. Thalamic transcriptome screening in three psychiatric states. J Hum Genet 2009; 54: 665-675.
135. Bousman CA, Chana G, Glatt SJ, Chandler SD, May T, Lohr J et al. Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 1336-1341.
136. Beck KA, Keen JH. Interaction of phosphoinositide cycle intermediates with the plasma membrane-associated clathrin assembly protein AP-2. J Biol Chem 1991; 266: 4442-4447. (Pubitemid 21909376)
137. Haucke V. Phosphoinositide regulation of clathrin-mediated endocytosis. Biochem Soc Trans 2005; 33(Pt 6): 1285-1289. (Pubitemid 41779669)
138. Jost M, Simpson F, Kavran JM, Lemmon MA, Schmid SL. Phosphatidylinositol- 4,5-bisphosphate is required for endocytic coated vesicle formation. Curr Biol 1998; 8: 1399-1402. (Pubitemid 29020150)
139. Krauss M, Kinuta M, Wenk MR, De Camilli P, Takei K, Haucke V. ARF6 stimulates clathrin/AP-2 recruitment to synaptic membranes by activating phosphatidylinositol phosphate kinase type Igamma. J Cell Biol 2003; 162: 113-124. (Pubitemid 36859539)
140. Varnai P, Thyagarajan B, Rohacs T, Balla T. Rapidly inducible changes in phosphatidylinositol 4,5-bisphosphate levels influence multiple regulatory functions of the lipid in intact living cells. J Cell Biol 2006; 175: 377-382. (Pubitemid 44708062)
141. Padrón D, Wang YJ, Yamamoto M, Yin H, Roth MG. Phosphatidylinositol phosphate 5-kinase Ibeta recruits AP-2 to the plasma membrane and regulates rates of constitutive endocytosis. J Cell Biol 2003; 162: 693-701. (Pubitemid 37022946)
142. Clague MJ, Urbé S, de Lartigue J. Phosphoinositides and the endocytic pathway. Exp Cell Res 2009; 315: 1627-1631.
143. Kim HJ, Thayer SA. Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol 2009; 75: 1021-1030.
144. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543. (Pubitemid 351590668)
145. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 2007; 8: 128-140. (Pubitemid 46146951)
146. Allen JA, Yadav PN, Setola V, Roth BL. The schizophrenia risk gene CAV1 is both pro-psychotic and required for antipsychotic drug activity at 5-HT2A serotonin receptors in vivo. In: Advancing Drug Discovery for Schizophrenia, Abstract Book. The New York Academy of Sciences: New York, 2011: 21.
147. Newell-Litwa K, Salazar G, Smith Y, Faundez V. Roles of BLOC-1 and adaptor protein-3 complexes in cargo sorting to synaptic vesicles. Mol Biol Cell 2009; 20: 1441-1453.
148. Setty SR, Tenza D, Truschel ST, Chou E, Sviderskaya EV, Theos AC et al. BLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organelles. Mol Biol Cell 2007; 18: 768-780. (Pubitemid 46399484)
149. Casas S, Casini P, Piquer S, Altirriba J, Soty M, Cadavez L et al. BACE2 plays a role in the insulin receptor trafficking in pancreatic-cells. Am J Physiol Endocrinol Metab 2010; 299: E1087-E1095.
150. Galletta BJ, Mooren OL, Cooper JA. Actin dynamics and endocytosis in yeast and mammals. Curr Opin Biotechnol 2010; 21: 604-610.
151. Edwards AM, Isserlin R, Bader GD, Frye SV, Willson TM, Yu FH. Too many roads not taken. Nature 2011; 470: 163-165.
152. Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol Psychiatry 2010; 15: 1088-1100.
153. Garrick MD, Garrick LM. Cellular iron transport. Biochim Biophys Acta 2009; 1790: 309-325.
154. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006; 10: 839-850. (Pubitemid 43779110)
155. Clarke MC, Tanskanen A, Huttunen M, Whittaker JC, Cannon M. Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry 2009; 166: 1025-1030.
156. O'Callaghan E, Sham P, Takei N, Glover G, Murray RM. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 1991; 337: 1248-1250.
157. Abbott A. Schizophrenia: the drug deadlock. Nature 2010; 468: 158-159.
158. The Lancet.Where will new drugs come from? Lancet 2011; 377: 97.
159. Chan MK, Tsang TM, Harris LW, Guest PC, Holmes E, Bahn S. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients. Mol Psychiatry 2010; doi:10.1038/mp.2010.100 (in press).
160. Zhou Y, Wang J, Wang K, Li S, Song X, Ye Y et al. Association analysis between the rs11136000 single nucleotide polymorphism in clusterin gene, rs3851179 single nucleotide polymorphism in clathrin assembly lymphoid myeloid protein gene and the patients with schizophrenia in the Chinese population. DNA Cell Biol 2010; 29: 745-751.
161. Smalla KH, Mikhaylova M, Sahin J, Bernstein HG, Bogerts B, Schmitt A et al. A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Mol Psychiatry 2008; 13: 878-896.
162. Vine AE, McQuillin A, Bass NJ, Pereira A, Kandaswamy R, Robinson M et al. No evidence for excess runs of homozygosity in bipolar disorder. Psychiatr Genet 2009; 19: 165-170.
163. Clark D, Dedova I, Cordwell S, Matsumoto I. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatry 2006; 11: 459-470, 423.
164. Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyás E, Eberlin MN et al. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res 2009; 43: 978-986.
165. Amar S, Shaltiel G, Mann L, Shamir A, Dean B, Scarr E et al. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. Int J Neuropsychopharmacol 2008; 11: 197-205. (Pubitemid 351231825)
166. Ikeda M, Ozaki N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y et al. Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav 2007; 6: 107-112. (Pubitemid 46090337)
167. Margolis RL, Abraham MR, Gatchell SB, Li SH, Kidwai AS, Breschel TS et al. cDNAs with long CAG trinucleotide repeats from human brain. Hum Genet 1997; 100: 114-122. (Pubitemid 27309665)
168. Passos Gregorio S, Gattaz WF, Tavares H, Kieling C, Timm S, Wang AG et al. Analysis of coding-polymorphisms in NOTCHrelated genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects. Schizophr Res 2006; 88: 275-282. (Pubitemid 44773731)
169. Potash JB, Buervenich S, Cox NJ, Zandi PP, Akula N, Steele J et al. Gene-based SNP mapping of a psychotic bipolar affective disorder linkage region on 22q12.3: association with HMG2L1 and TOM1. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 59-67.
170. Saito T, Guan F, Papolos DF, Wolyniec PS, Mitchell AA, Shetty AC et al. Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol Psychiatry 2001; 6: 387-395. (Pubitemid 32566087)
171. Stopkova P, Vevera J, Paclt I, Zukov I, Lachman HM. Analysis of SYNJ1, a candidate gene for 21q22 linked bipolar disorder: a replication study. Psychiatry Res 2004; 127: 157-161. (Pubitemid 38916876)
172. Sivagnanasundaram S, Crossett B, Dedova I, Cordwell S, Matsumoto I. Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study. Proteomics Clin Appl 2007; 1: 1291-1305.